Abstract:Graphene oxide (GO), as a two-dimensional carbon nanosheet, has been extensively studied for potential biomedical applications due to its notable properties. Although a growing number of studies have investigated the adverse effects of GO nanosheets, the available toxicity data concerning GO's effect on the neuronal cells remain highly limited. In this work, we systematically investigated the toxic responses of commercially available GO on a rat pheochromocytoma-derived PC12 cell line, which was an ideal in vitro model to study the neurotoxicity of GO. GO exerted a significant toxic effect on PC12 cells in a dose- and time-dependent manner. GO treatments under doses of 40, 50, and 60 mu g/mL triggered an autophagic response and the blockade of autophagic flux via disrupting lysosome degradation capability. Caspase 9-mediated apoptosis was also observed in GO-treated cells. Moreover, GO-induced apoptosis was relevant to the aberrant accumulation of autophagy substrate p62/SQSTM. Inhibition of the accumulation of autophagic substrate alleviated GO-caused apoptotic cell death. Our findings raise a concern for the putative biomedical applications of GO in the form of diagnostic and therapeutic tools, where its systematic biocompatibility should be thoroughly explored. Statement of significance Graphene oxide (GO) has attracted considerable interests in biomedical fields, which also resulted in numerous safety risks to human bodies. It is urgently required to establish a paradigm for accurately evaluating their adverse effects in biological systems. This study thoroughly explored the neurotoxicity of GO in PC12 cells. We found GO triggered an increased autophagic response and the impairment of autophagic flux, which was functionally involved in cell apoptosis. Inhibition of excessive accumulation of autophagic cargo attenuated apoptotic cell death. Our findings highlight deep considerations on the regulation mechanism of autophagy-lysosomes-apotosis-axis, which will contribute to a better understanding of the neurotoxicity of graphene-family nanomaterials, and provide a new insight in the treatment of cancer cells at nanoscale levels. (C) 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Blood exposure to graphene oxide may cause anaphylactic death in non-human primates

Size‐Dependent Pulmonary Impact of Thin Graphene Oxide Sheets in Mice: Toward Safe‐by‐Design

Next-Generation Sequencing Reveals Differential Responses to Acute versus Long-Term Exposures to Graphene Oxide in Human Lung Cells

[Immunogenic and toxic effects of graphene oxide nanoparticles in mouse skeletal muscles and human red blood cells]

Biocompatibility of graphene oxide intravenously administrated in mice—effects of dose, size and exposure protocols

Surface Oxidation of Graphene Oxide Determines Membrane Damage, Lipid Peroxidation, and Cytotoxicity in Macrophages in a Pulmonary Toxicity Model

Toxicological Effects of Graphene Oxide on Saccharomyces Cerevisiae.

Evaluation of the Toxicity of Graphene Oxide Exposure to the Eye

Toxicity of Graphene Oxide and Multi-Walled Carbon Nanotubes Against Human Cells and Zebrafish

Estimation of genomic instability and mutation induction by graphene oxide nanoparticles in mice liver and brain tissues

Cytotoxicity Effect of Graphene Oxide on Human MDA-MB-231 Cells

Graphene Oxide Induces P62/sqstm-Dependent Apoptosis Through the Impairment of Autophagic Flux and Lysosomal Dysfunction in PC12 Cells.

Graphene Oxide Toxicity in W1118 Flies

Graphene Oxide (GO) Sub Chronic Toxicity in Liver, Kidney and Spleen: Macroscopic Observation and Histo-biochemical Examination

Dependence of Graphene Oxide (GO) Toxicity on Oxidation Level, Elemental Composition, and Size

Graphene Oxide Modulates B Cell Surface Phenotype and Impairs Immunoglobulin Secretion in Plasma Cell

Altered immune cells in the liver and spleen of mice as a typical immune response to graphene oxide exposure

Induction of chromosomal and DNA damage and histological alterations by graphene oxide nanoparticles in Swiss mice

Distribution and Biocompatibility Studies of Graphene Oxide in Mice after Intravenous Administration

Nanotoxicity of different sizes of graphene (G) and graphene oxide (GO) in vitro and in vivo.

Toxicity of Low-dose Graphene Oxide Nanoparticles in an In-Vivo Wild Type of Caenorhabditis Elegans Model